Raymond James analyst Andrew Cooper initiates coverage on Myriad Genetics (NASDAQ:MYGN) with a Market Perform rating.
Deutsche Bank Maintains Hold on Vail Resorts, Lowers Price Target to $283
Deutsche Bank analyst Chris Woronka maintains Vail Resorts (NYSE:MTN) with a Hold and lowers the price target from $286 to $283.